8-(1-Cyclohexyl-1H-benzo[d]imidazole-6-yl)-6-(thiophen-3-yl)imidazo[1,2-a]pyrazine

ID: ALA5283295

Max Phase: Preclinical

Molecular Formula: C23H21N5S

Molecular Weight: 399.52

Names and Identifiers

Canonical SMILES:  c1cn2cc(-c3ccsc3)nc(-c3ccc4ncn(C5CCCCC5)c4c3)c2n1

Standard InChI:  InChI=1S/C23H21N5S/c1-2-4-18(5-3-1)28-15-25-19-7-6-16(12-21(19)28)22-23-24-9-10-27(23)13-20(26-22)17-8-11-29-14-17/h6-15,18H,1-5H2

Standard InChI Key:  RQCQWKXOJZMODH-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 34  0  0  0  0  0  0  0  0999 V2000
   28.4393  -24.1277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4382  -24.9473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1462  -25.3562    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.8559  -24.9468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1444  -23.7189    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.8502  -24.1272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4567  -23.5821    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.1257  -22.8368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3147  -22.9215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5648  -25.3494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5662  -26.1677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9764  -25.3415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2676  -24.9390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9817  -26.1629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2782  -26.5752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4529  -27.3717    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.2644  -27.4517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5912  -26.7046    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.9145  -27.9821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1135  -27.8152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5715  -28.4220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8251  -29.1993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6261  -29.3661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1734  -28.7558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7328  -25.3586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9866  -25.0256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4393  -25.6325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8473  -26.3406    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   27.6467  -26.1712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  1  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
 10 11  2  0
 11 15  1  0
 14 12  1  0
 12 13  2  0
 13 10  1  0
  4 10  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 14  1  0
 19 20  1  0
 19 24  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 16 19  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 29 25  2  0
  2 25  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA5283295

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 399.52

Molecular Weight (Monoisotopic): 399.1518

AlogP: 5.98

#Rotatable Bonds: 3

Polar Surface Area: 48.01

Molecular Species: NEUTRAL

HBA: 6

HBD: ┄

#RO5 Violations: 1

HBA (Lipinski): 5

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): 1

CX Acidic pKa: ┄

CX Basic pKa: 5.03

CX LogP: 4.70

CX LogD: 4.70

Aromatic Rings: 5

Heavy Atoms: 29

QED Weighted: 0.37

Np Likeness Score: -1.73

References

1. Singh I, Luxami V, Paul K..  (2019)  Effective synthesis of benzimidazoles-imidazo[1,2-a]pyrazine conjugates: A comparative study of mono-and bis-benzimidazoles for antitumor activity.,  180  [PMID:31344614] [10.1016/j.ejmech.2019.07.042]

Source

Source(1):

• Scientific Literature